Molecular imaging reveals unique degenerative changes in experimental glaucoma

Lmamura K., Onoe H., Shimazawa M., Nozaki S., Wada Y., Kato K., Nakajima H., Mizuma H., Onoe K., Taniguchi T., Sasaoka M., Hara H., Tanaka S., Araie M., Watanabe Y.

2009
NeuroReport

View publication

Therapeutic Area

Glaucoma
Categories

Preclinical development

Affiliations

Department of Systems Life Engineering, Maebashi Institute of Technology, Maebashi-shi, Japan; Department of Physiology, Osaka City University Graduate, School of Medicine, Osaka, Japan; Laboratory of Visual Neurocomputing, Brain Science Institute, RIKEN, Saitama, Japan; Molecular Imaging Research Program, RIKEN, Kobe, Japan; Department of Biofunctional Evaluation, Molecular Pharmacology, Gifu Pharmaceutical University, Mitahora-higashi, Gifu, Japan; Glaucoma Group, Research and Development Center, Santen Pharmaceutical Co. Ltd., Ikoma, Japan; Department of Ophthalmology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan; Department of Systems Life Engineering, Maebashi Institute of Technology, 460-1 Kamisadori-machi, Maebashi-shi, Gunma 371-0816, Japan

Related Publications

Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial

Wang T.H.; Aung T.; Lu D.-W.; George R.; Senthil S.; Lu F.; Odani-Kawabata N.; Park K.H.

Efficacy and Safety of a Preservative-Free Latanoprost Cationic Emulsion in Patients with Open-Angle Glaucoma and Concurrent Ocular Surface Disease: A Randomized Phase 2 Study.

Bacharach, Jason; McLaurin, Eugene B.; Silverstein, Steven; Amrane, Mourad; Garrigue, Jean-Sebastien; Ismail, Dahlia; Flynn, William J.; Catiolanze Phase 2 study group

Assessment of Brain-Derived Neurotrophic Factor on Retinal Structure and Visual Function in Rodent Models of Optic Nerve Crush

Taniguchi T.; Sharif N.A.; Ota T.; Farjo R.A.; Rausch R.

View all Glaucoma publications